Parkside Investments’s Viatris VTRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
– Sell
-63
Closed – – 159
2022
Q1
$0 Buy
+63
New +$830 ﹤0.01% 168
2019
Q2
– Sell
-45,905
Closed -$1.3M – 114
2019
Q1
$1.3M Buy
45,905
+9,135
+25% +$266K 0.35% 72
2018
Q4
$1.01M Buy
36,770
+8,995
+32% +$291K 0.44% 65
2018
Q3
$1.02M Sell
27,775
-2,025
-7% -$76K 0.48% 56
2018
Q2
$1.08M Sell
29,800
-275
-0.9% -$10.8K 0.53% 54
2018
Q1
$1.24M Sell
30,075
-9,775
-25% -$417K 0.64% 48
2017
Q4
$1.69M Buy
39,850
+2,200
+6% +$84.1K 0.82% 45
2017
Q3
$1.18M Sell
37,650
-13,200
-26% -$448K 0.68% 47
2017
Q2
$1.97M Buy
50,850
+375
+0.7% +$14.4K 1.23% 41
2017
Q1
$1.97M Buy
+50,475
New +$2.03M 1.39% 40

Other funds holding VTRS

Parkside Investments's VTRS Position: Q2 2022 in Review

Parkside Investments sold out of Viatris (VTRS) in Q2 2022, closing a stake of 63 shares.

Parkside Investments first reported a position in VTRS in Q1 2017 and held it in 10 quarters. The position peaked at $1.97M in Q2 2017. 1,010 funds tracked by Wall St. Rank hold VTRS as of Q2 2022.

  • Parkside Investments reported no remaining Viatris position as of Q2 2022 after selling out during the quarter.
  • Parkside Investments sold 63 Viatris shares in Q2 2022.
  • Parkside Investments first reported a position in Viatris in Q1 2017 and held it in 10 quarters.
  • Parkside Investments's Viatris position peaked at $1.97M in Q2 2017.
  • 1,010 funds tracked by Wall St. Rank held Viatris as of Q2 2022.

Based on Parkside Investments's 13F filing for Q2 2022, filed 13 Jul 2022.